Alok Khorana: Six Years of Growth and Transformation at National Blood Clot Alliance
Alok Khorana, Vice Chair of the Taussig Cancer Institute at Cleveland Clinic, shared a post on LinkedIn:
“It’s been a dynamic six years of growth and transformation as I reach the end of my second and final term as Chair of the Medical and Scientific Advisory Board of National Blood Clot Alliance. From creating the Council for Emerging Researchers in Thrombosis (CERT) to effective public policy advances at state and federal levels such as the passage of the Emily Adkins Act in Florida, I couldn’t have asked for a better partner than Leslie Lake. She is an inspirational leader who has changed the boundaries of what’s possible in this patient-led organization.
I’m excited to hand off leadership to incoming Chair Jeffrey Zwicker who I’m absolutely confident will lead the Board to newer and greater heights.
Finally, I’m absolutely delighted to remain involved with MASAB and NBCA as Chair Emeritus. Much has been done to alleviate the public health and individual burden of thromboembolism but much remains to be done.”
Stay updated with Hemostasis Today.
-
Aug 22, 2026, 11:36Bernardo Gindri: How platelets Influence Cancer Progression
-
Aug 22, 2026, 11:34Nick Gehrig: Extending Platelet Shelf Life to Strengthen Blood Supply
-
Aug 22, 2026, 11:14Lei Yu: New Guidance for Acute Pulmonary Embolism in 2026
-
Aug 22, 2026, 11:01Neeraj Songara: Shelf-Stable Synthetic Blood – The Future of Emergency Transfusion?
-
Aug 22, 2026, 10:41Mike R.։ VTE Thrombectomy – Defining What Success Really Means
-
Aug 22, 2026, 10:28Steven Meier: What Happens During PRP Therapy?
-
Aug 22, 2026, 10:05Ralf Ludwig: When a Promising Biomarker Falls Short
-
Aug 22, 2026, 09:33Mary Cushman: What Causes PE to Happen in People with DVT?
-
Aug 22, 2026, 07:45Ziad Hijazi: Refining Risk Assessment in Atrial Fibrillation Without Oral Anticoagulation